Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
18
NCT06904872
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Phase: Phase 2
Role: Lead Sponsor
Start: May 29, 2025
Completion: Feb 28, 2026